CHEK2 and thyroid gland papillary carcinoma: Furthermore, a case-control study reported a CHEK2 mutation in 15.6% of unselected patients with papillary thyroid cancer, compared to 6.0% in age- and sex-matched controls (OR = 3.3, p < 0.0001) (43).